This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Arsura, M.
Right arrow Articles by Sonenshein, G. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Arsura, M.
Right arrow Articles by Sonenshein, G. E.

 Previous Article  |  Next Article 

Molecular and Cellular Biology, August 2000, p. 5381-5391, Vol. 20, No. 15
0270-7306/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.

Role of the Ikappa B Kinase Complex in Oncogenic Ras- and Raf-Mediated Transformation of Rat Liver Epithelial Cells

Marcello Arsura,1,* Frank Mercurio,2 Aundrea L. Oliver,1 Snorri S. Thorgeirsson,3 and Gail E. Sonenshein1

Department of Biochemistry, Boston University School of Medicine, Boston, Massachusetts 02118-23941; Signal Pharmaceuticals, Inc., San Diego, California 921212; and Laboratory of Experimental Carcinogenesis, Division of Basic Sciences, National Cancer Institute, Bethesda, Maryland 208923

Received 17 November 1999/Returned for modification 5 January 2000/Accepted 10 April 2000

NF-kappa B/Rel factors have been implicated in the regulation of liver cell death during development, after partial hepatectomy, and in hepatocytes in culture. Rat liver epithelial cells (RLEs) display many biochemical and ultrastructural characteristics of oval cells, which are multipotent cells that can differentiate into mature hepatocytes. While untransformed RLEs undergo growth arrest and apoptosis in response to transforming growth factor beta 1 (TGF-beta 1) treatment, oncogenic Ras- or Raf-transformed RLEs are insensitive to TGF-beta 1-mediated growth arrest. Here we have tested the hypothesis that Ras- or Raf-transformed RLEs have altered NF-kappa B regulation, leading to this resistance to TGF-beta 1. We show that classical NF-kappa B is aberrantly activated in Ras- or Raf-transformed RLEs, due to increased phosphorylation and degradation of Ikappa B-alpha protein. Inhibition of NF-kappa B activity with a dominant negative form of Ikappa B-alpha restored TGF-beta 1-mediated cell killing of transformed RLEs. IKK activity mediates this hyperphosphorylation of Ikappa B-alpha protein. As judged by kinase assays and transfection of dominant negative IKK-1 and IKK-2 expression vectors, NF-kappa B activation by Ras appeared to be mediated by both IKK-1 and IKK-2, while Raf-induced NF-kappa B activation was mediated by IKK-2. NF-kappa B activation in the Ras-transformed cells was mediated by both the Raf and phosphatidylinositol 3-kinase pathways, while in the Raf-transformed cells, NF-kappa B induction was mediated by the mitogen-activated protein kinase cascade. Last, inhibition of either IKK-1 or IKK-2 reduced focus-forming activity in Ras-transformed RLEs. Overall, these studies elucidate a mechanism that contributes to the process of transformation of liver cells by oncogene Ras and Raf through the Ikappa B kinase complex leading to constitutive activation of NF-kappa B.


* Corresponding author. Mailing address: Department of Biochemistry, Boston University School of Medicine, 715 Albany St., Boston, MA 02118. Phone: (617) 638-4129. Fax: (617) 638-4252. E-mail: marsura{at}bu.edu.


Molecular and Cellular Biology, August 2000, p. 5381-5391, Vol. 20, No. 15
0270-7306/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.



This article has been cited by other articles:

  • Wu, M., Min, C., Wang, X., Yu, Z., Kirsch, K. H., Trackman, P. C., Sonenshein, G. E. (2007). Repression of BCL2 by the Tumor Suppressor Activity of the Lysyl Oxidase Propeptide Inhibits Transformed Phenotype of Lung and Pancreatic Cancer Cells. Cancer Res. 67: 6278-6285 [Abstract] [Full Text]  
  • Min, C., Kirsch, K. H., Zhao, Y., Jeay, S., Palamakumbura, A. H., Trackman, P. C., Sonenshein, G. E. (2007). The Tumor Suppressor Activity of the Lysyl Oxidase Propeptide Reverses the Invasive Phenotype of Her-2/neu-Driven Breast Cancer. Cancer Res. 67: 1105-1112 [Abstract] [Full Text]  
  • Hezel, A. F., Kimmelman, A. C., Stanger, B. Z., Bardeesy, N., DePinho, R. A. (2006). Genetics and biology of pancreatic ductal adenocarcinoma.. Genes Dev. 20: 1218-1249 [Abstract] [Full Text]  
  • Shin, S. R., Sanchez-Velar, N., Sherr, D. H., Sonenshein, G. E. (2006). 7,12-Dimethylbenz(a)Anthracene Treatment of a c-rel Mouse Mammary Tumor Cell Line Induces Epithelial to Mesenchymal Transition via Activation of Nuclear Factor-{kappa}B.. Cancer Res. 66: 2570-2575 [Abstract] [Full Text]  
  • Tanaka, H., Fujita, N., Tsuruo, T. (2005). 3-Phosphoinositide-dependent Protein Kinase-1-mediated I{kappa}B Kinase {beta} (IKKB) Phosphorylation Activates NF-{kappa}B Signaling. J. Biol. Chem. 280: 40965-40973 [Abstract] [Full Text]  
  • Guo, S., Yang, S., Taylor, C., Sonenshein, G. E. (2005). Green Tea Polyphenol Epigallocatechin-3 Gallate (EGCG) Affects Gene Expression of Breast Cancer Cells Transformed by the Carcinogen 7,12-Dimethylbenz[a]Anthracene. J. Nutr. 135: 2978S-2986S [Abstract] [Full Text]  
  • Kaur, S., Wang, F., Venkatraman, M., Arsura, M. (2005). X-linked Inhibitor of Apoptosis (XIAP) Inhibits c-Jun N-terminal Kinase 1 (JNK1) Activation by Transforming Growth Factor {beta}1 (TGF-{beta}1) through Ubiquitin-mediated Proteosomal Degradation of the TGF-{beta}1-activated Kinase 1 (TAK1). J. Biol. Chem. 280: 38599-38608 [Abstract] [Full Text]  
  • Cavin, L. G., Wang, F., Factor, V. M., Kaur, S., Venkatraman, M., Thorgeirsson, S. S., Arsura, M. (2005). Transforming Growth Factor-{alpha} Inhibits the Intrinsic Pathway of c-Myc-Induced Apoptosis through Activation of Nuclear Factor-{kappa}B in Murine Hepatocellular Carcinomas. Mol Cancer Res 3: 403-412 [Abstract] [Full Text]  
  • Simile, M. M., Pagnan, G., Pastorino, F., Brignole, C., De Miglio, M. R., Muroni, M. R., Asara, G., Frau, M., Seddaiu, M. A., Calvisi, D. F., Feo, F., Ponzoni, M., Pascale, R. M. (2005). Chemopreventive N-(4-hydroxyphenyl)retinamide (fenretinide) targets deregulated NF-{kappa}B and Mat1A genes in the early stages of rat liver carcinogenesis. Carcinogenesis 26: 417-427 [Abstract] [Full Text]  
  • Lee, S., Andrieu, C., Saltel, F., Destaing, O., Auclair, J., Pouchkine, V., Michelon, J., Salaun, B., Kobayashi, R., Jurdic, P., Kieff, E. D., Sylla, B. S. (2004). I{kappa}B kinase {beta} phosphorylates Dok1 serines in response to TNF, IL-1, or {gamma} radiation. Proc. Natl. Acad. Sci. USA 101: 17416-17421 [Abstract] [Full Text]  
  • Hanson, J. L., Hawke, N. A., Kashatus, D., Baldwin, A. S. (2004). The Nuclear Factor {kappa}B Subunits RelA/p65 and c-Rel Potentiate but Are Not Required for Ras-Induced Cellular Transformation. Cancer Res. 64: 7248-7255 [Abstract] [Full Text]  
  • Chen, B.-C., Yu, C.-C., Lei, H.-C., Chang, M.-S., Hsu, M.-J., Huang, C.-L., Chen, M.-C., Sheu, J.-R., Chen, T.-F., Chen, T.-L., Inoue, H., Lin, C.-H. (2004). Bradykinin B2 Receptor Mediates NF-{kappa}B Activation and Cyclooxygenase-2 Expression via the Ras/Raf-1/ERK Pathway in Human Airway Epithelial Cells. J. Immunol. 173: 5219-5228 [Abstract] [Full Text]  
  • Cavin, L. G., Venkatraman, M., Factor, V. M., Kaur, S., Schroeder, I., Mercurio, F., Beg, A. A., Thorgeirsson, S. S., Arsura, M. (2004). Regulation of {alpha}-Fetoprotein by Nuclear Factor-{kappa}B Protects Hepatocytes from Tumor Necrosis Factor-{alpha} Cytotoxicity during Fetal Liver Development and Hepatic Oncogenesis. Cancer Res. 64: 7030-7038 [Abstract] [Full Text]  
  • van Empel, V. P.M, De Windt, L. J (2004). Myocyte hypertrophy and apoptosis: a balancing act. Cardiovasc Res 63: 487-499 [Abstract] [Full Text]  
  • Na, H.-J., Lee, S.-J., Kang, Y.-C., Cho, Y.-L., Nam, W.-D., Kim, P. K. M., Ha, K.-S., Chung, H.-T., Lee, H., Kwon, Y.-G., Koh, J. S., Kim, Y.-M. (2004). Inhibition of Farnesyltransferase Prevents Collagen-Induced Arthritis by Down-Regulation of Inflammatory Gene Expression through Suppression of p21ras-Dependent NF-{kappa}B Activation. J. Immunol. 173: 1276-1283 [Abstract] [Full Text]  
  • Chen, B.-C., Chang, Y.-S., Kang, J.-C., Hsu, M.-J., Sheu, J.-R., Chen, T.-L., Teng, C.-M., Lin, C.-H. (2004). Peptidoglycan Induces Nuclear Factor-{kappa}B Activation and Cyclooxygenase-2 Expression via Ras, Raf-1, and ERK in RAW 264.7 Macrophages. J. Biol. Chem. 279: 20889-20897 [Abstract] [Full Text]  
  • Chandramohan, V., Jeay, S., Pianetti, S., Sonenshein, G. E. (2004). Reciprocal Control of Forkhead box O 3a and c-Myc via the Phosphatidylinositol 3-Kinase Pathway Coordinately Regulates p27Kip1 Levels. J. Immunol. 172: 5522-5527 [Abstract] [Full Text]  
  • Bilyeu, J. D., Panta, G. R., Cavin, L. G., Barrett, C. M., Turner, E. J., Sweatman, T. W., Israel, M., Lothstein, L., Arsura, M. (2004). Circumvention of Nuclear Factor {kappa}B-Induced Chemoresistance by Cytoplasmic-Targeted Anthracyclines. Mol. Pharmacol. 65: 1038-1047 [Abstract] [Full Text]  
  • Panta, G. R., Kaur, S., Cavin, L. G., Cortes, M. L., Mercurio, F., Lothstein, L., Sweatman, T. W., Israel, M., Arsura, M. (2004). ATM and the Catalytic Subunit of DNA-Dependent Protein Kinase Activate NF-{kappa}B through a Common MEK/Extracellular Signal-Regulated Kinase/p90rsk Signaling Pathway in Response to Distinct Forms of DNA Damage. Mol. Cell. Biol. 24: 1823-1835 [Abstract] [Full Text]  
  • Nemeth, Z. H., Wong, H. R., Odoms, K., Deitch, E. A., Szabo, C., Vizi, E. S., Hasko, G. (2004). Proteasome Inhibitors Induce Inhibitory {kappa}B (I{kappa}B) Kinase Activation, I{kappa}B{alpha} Degradation, and Nuclear Factor {kappa}B Activation in HT-29 Cells. Mol. Pharmacol. 65: 342-349 [Abstract] [Full Text]  
  • Starenki, D., Namba, H., Saenko, V., Ohtsuru, A., Yamashita, S. (2004). Inhibition of Nuclear Factor-{kappa}B Cascade Potentiates the Effect of a Combination Treatment of Anaplastic Thyroid Cancer Cells. J. Clin. Endocrinol. Metab. 89: 410-418 [Abstract] [Full Text]  
  • Dadke, D., Fryer, B. H., Golemis, E. A., Field, J. (2003). Activation of p21-Activated Kinase 1-Nuclear Factor {kappa}B Signaling by Kaposi's Sarcoma-Associated Herpes Virus G Protein-Coupled Receptor during Cellular Transformation. Cancer Res. 63: 8837-8847 [Abstract] [Full Text]  
  • Hanson, J. L., Anest, V., Reuther-Madrid, J., Baldwin, A. S. (2003). Oncoprotein Suppression of Tumor Necrosis Factor-induced NF{kappa}B Activation Is Independent of Raf-controlled Pathways. J. Biol. Chem. 278: 34910-34917 [Abstract] [Full Text]  
  • Romieu-Mourez, R., Kim, D. W., Shin, S. M., Demicco, E. G., Landesman-Bollag, E., Seldin, D. C., Cardiff, R. D., Sonenshein, G. E. (2003). Mouse Mammary Tumor Virus c-rel Transgenic Mice Develop Mammary Tumors. Mol. Cell. Biol. 23: 5738-5754 [Abstract] [Full Text]  
  • Jeay, S., Pianetti, S., Kagan, H. M., Sonenshein, G. E. (2003). Lysyl Oxidase Inhibits Ras-Mediated Transformation by Preventing Activation of NF-{kappa}B. Mol. Cell. Biol. 23: 2251-2263 [Abstract] [Full Text]  
  • Tian, B., Brasier, A. R. (2003). Identification of a Nuclear Factor Kappa B-dependent Gene Network. Recent Prog Horm Res 58: 95-130 [Abstract] [Full Text]  
  • Romieu-Mourez, R., Landesman-Bollag, E., Seldin, D. C., Sonenshein, G. E. (2002). Protein Kinase CK2 Promotes Aberrant Activation of Nuclear Factor-{kappa}B, Transformed Phenotype, and Survival of Breast Cancer Cells. Cancer Res. 62: 6770-6778 [Abstract] [Full Text]  
  • Spiegelman, V. S., Tang, W., Chan, A. M., Igarashi, M., Aaronson, S. A., Sassoon, D. A., Katoh, M., Slaga, T. J., Fuchs, S. Y. (2002). Induction of Homologue of Slimb Ubiquitin Ligase Receptor by Mitogen Signaling. J. Biol. Chem. 277: 36624-36630 [Abstract] [Full Text]  
  • Tian, B., Zhang, Y., Luxon, B. A., Garofalo, R. P., Casola, A., Sinha, M., Brasier, A. R. (2002). Identification of NF-{kappa}B-Dependent Gene Networks in Respiratory Syncytial Virus-Infected Cells. J. Virol. 76: 6800-6814 [Abstract] [Full Text]  
  • Koteish, A., Yang, S., Lin, H., Huang, X., Diehl, A. M. (2002). Chronic Ethanol Exposure Potentiates Lipopolysaccharide Liver Injury Despite Inhibiting Jun N-terminal Kinase and Caspase 3 Activation. J. Biol. Chem. 277: 13037-13044 [Abstract] [Full Text]  
  • Russell, J. S., Raju, U., Gumin, G. J., Lang, F. F., Wilson, D. R., Huet, T., Tofilon, P. J. (2002). Inhibition of Radiation-induced Nuclear Factor-{kappa}B Activation by an Anti-Ras Single-Chain Antibody Fragment: Lack of Involvement in Radiosensitization. Cancer Res. 62: 2318-2326 [Abstract] [Full Text]  
  • Arlt, A., Vorndamm, J., Muerkoster, S., Yu, H., Schmidt, W. E., Folsch, U. R., Schafer, H. (2002). Autocrine Production of Interleukin 1{beta} Confers Constitutive Nuclear Factor {kappa}B Activity and Chemoresistance in Pancreatic Carcinoma Cell Lines. Cancer Res. 62: 910-916 [Abstract] [Full Text]  
  • Davis, R. E., Brown, K. D., Siebenlist, U., Staudt, L. M. (2001). Constitutive Nuclear Factor {kappa}B Activity Is Required for Survival of Activated B Cell-like Diffuse Large B Cell Lymphoma Cells. JEM 194: 1861-1874 [Abstract] [Full Text]  
  • TEGEDER, I., PFEILSCHIFTER, J., GEISSLINGER, G. (2001). Cyclooxygenase-independent actions of cyclooxygenase inhibitors. FASEB J. 15: 2057-2072 [Abstract] [Full Text]  
  • Yang, S., Lin, H., Diehl, A. M. (2001). Fatty liver vulnerability to endotoxin-induced damage despite NF-{kappa}B induction and inhibited caspase 3 activation. Am. J. Physiol. Gastrointest. Liver Physiol. 281: G382-G392 [Abstract] [Full Text]  
  • Yang, S., Lin, H. Z., Hwang, J., Chacko, V. P., Diehl, A. M. (2001). Hepatic Hyperplasia in Noncirrhotic Fatty Livers: Is Obesity-related Hepatic Steatosis a Premalignant Condition?. Cancer Res. 61: 5016-5023 [Abstract] [Full Text]  
  • Jeay, S., Sonenshein, G. E., Kelly, P. A., Postel-Vinay, M.-C., Baixeras, E. (2001). Growth Hormone Exerts Antiapoptotic and Proliferative Effects through Two Different Pathways Involving Nuclear Factor-{{kappa}}B and Phosphatidylinositol 3-Kinase. Endocrinology 142: 147-156 [Abstract] [Full Text]